Conclusion
Systems biology is evolving to meet the needs of researchers and drug developers who must extract meaningful, applicable knowledge out of an overwhelming—and growing—amount of biological data. Armed with a greater understanding of the complexity of disease, industry will be better positioned to populate development pipelines with more promising drug candidates and help make predictive, preventive, and personalized medicine a reality.